SCHEMBL3733416

SCHEMBL3733416

O=C(Nc1nnc(Cc2cccnc2)s1)c1ccc2c(c1)CCNC2

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.57
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
POLB P06746 2/20 0.52
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
ALDH1A1 P00352 1/20 0.47
RXFP1 Q9HBX9 2/20 0.47
RPS6KA2 Q15349 1/20 0.46
GLS O94925 3/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
DGAT1 O75907 2/20 0.42
KDM4E B2RXH2 1/20 0.42
PTGER3 P43115 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3725736 0.99 LMNA (0.56) LMNAMEN1KMT2APOLBNPC1
SCHEMBL3733167 0.90 NPC1 (0.61) LMNAMEN1KMT2APOLBNPC1
Hydrochloric Acid SCHEMBL3727344 0.89 NPC1 (0.60) LMNAMEN1KMT2APOLBNPC1
SCHEMBL4563945 0.85 POLB (0.48) LMNAMEN1KMT2APOLBSMN1; SMN2
SCHEMBL3723613 0.85 DGAT1 (0.56) LMNAMEN1KMT2APOLBNPC1
SCHEMBL13347628 0.85 ALDH1A1 (0.49) LMNAMEN1KMT2APOLBNPC1
SCHEMBL3729167 0.85 RXFP1 (0.52) MEN1KMT2ANPC1RAB9ARXFP1
Hydrochloric Acid SCHEMBL3728324 0.85 DGAT1 (0.55) MEN1KMT2APOLBNPC1RAB9A
Hydrochloric Acid SCHEMBL3733934 0.84 LMNA (0.49) LMNAMEN1KMT2APOLBNPC1
Hydrochloric Acid SCHEMBL3732897 0.84 RXFP1 (0.51) MEN1KMT2ANPC1RAB9ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100120669-A1 THIADIAZOLE DERIVATIVES, INHIBITORS OF STEAROYL-COA DESATURASE BOUILLOT ANNE MARIE JEANNE 2010-05-13 US claimed
US-20100120669-A1 THIADIAZOLE DERIVATIVES, INHIBITORS OF STEAROYL-COA DESATURASE BOUILLOT ANNE MARIE JEANNE 2010-05-13 US disclosed
EP-2125799-A1 THIADIAZOLE DERIVATIVES, INHIBITORS OF STEAROYL-COA DESATURASE Smithkline Beecham Corporation (US) 2009-12-02 EP disclosed
WO-2008104524-A1 THIADIAZOLE DERIVATIVES, INHIBITORS OF STEAROYL-COA DESATURASE SMITHKLINE BEECHAM CORPORATION (US) 2008-09-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120669-A1 THIADIAZOLE DERIVATIVES, INHIBITORS OF STEAROYL-COA DESATURASE SCD, SCD5, FADS2 LMNA 2761/4885MEN1 4844/4885KMT2A 3443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.